Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orthofix Medical (OFIX) Other Accumulated Expenses (2016 - 2025)

Orthofix Medical (OFIX) has disclosed Other Accumulated Expenses for 16 consecutive years, with $111.3 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Other Accumulated Expenses fell 6.57% year-over-year to $111.3 million, compared with a TTM value of $111.3 million through Dec 2025, down 6.57%, and an annual FY2025 reading of $111.3 million, down 6.57% over the prior year.
  • Other Accumulated Expenses was $111.3 million for Q4 2025 at Orthofix Medical, up from $108.6 million in the prior quarter.
  • Across five years, Other Accumulated Expenses topped out at $119.1 million in Q4 2024 and bottomed at $48.2 million in Q2 2022.
  • Average Other Accumulated Expenses over 5 years is $85.2 million, with a median of $90.4 million recorded in 2023.
  • The sharpest move saw Other Accumulated Expenses fell 27.88% in 2022, then skyrocketed 101.15% in 2023.
  • Year by year, Other Accumulated Expenses stood at $76.8 million in 2021, then decreased by 27.88% to $55.4 million in 2022, then skyrocketed by 89.45% to $104.9 million in 2023, then increased by 13.5% to $119.1 million in 2024, then decreased by 6.57% to $111.3 million in 2025.
  • Business Quant data shows Other Accumulated Expenses for OFIX at $111.3 million in Q4 2025, $108.6 million in Q3 2025, and $102.5 million in Q2 2025.